Synopsis: Cipla’s Q3 net profit fell 57% YoY to Rs. 674 cr due to a Rs. 1,107 cr acquisition of diabetes drug rights and a Rs. 276 cr rise in gratuity and leave liabilities under India’s new labour codes. This is one of the leading Indian pharmaceutical companies...
Synopsis: Several Indian banks, including Bank of India, Indian Overseas Bank, Yes Bank, Union Bank, and HDFC Bank, reported lower net NPAs in Q3FY26, supported by strong profit growth, higher net interest income, and improving asset quality. In Q3FY26, several Indian...
Synopsis: Radico Khaitan shares rose 6 percent after strong Q3FY26 results, reporting 19.5 percent revenue growth, 45 percent YoY EBITDA growth by 45 percent to Rs. 265 crore, 62 percent net profit jump to Rs. 155 crore. This company is one of the most recognised IMFL...
Synopsis: Ujjivan Small Finance Bank, focused on financial inclusion, reported a 71% YoY and 49% QoQ rise in net profit to Rs. 182 cr in Q3FY26, with total income at Rs. 2,047 cr. This is a mass market-focused bank in India, catering to financially unserved and...
Synopsis: Sigachi Industries is in focus after achieving a key R&D milestone in Cystic Fibrosis APIs, targeting Rs. 250 crore annual revenue from Q4 FY27, strengthening its move into complex, high-value speciality pharmaceuticals. This company is one of the...
Synopsis: Dalmia Bharat shares gained 2% after Q3FY26 results, with revenue rising 10% YoY, net profit nearly doubling to Rs. 128 crore, and sales volumes increasing 9.5%, signalling strong performance. This company is engaged in the business of manufacturing and...
Synopsis: Maruti Securities shares jumped over 10% after Maruti Global Industries secured a Rs. 9.54 crore railway track work order from KMC Constructions, part of a South Central Railways EPC project, strengthening its infrastructure execution outlook. This company...
Synopsis: Piccadilly Agro Industries jumped 15% after reporting a strong 95% YoY growth in Q3FY26 net profit to Rs. 47.6 crore, with revenue up 51% to Rs. 313.8 crore, led by robust distillery performance. This is an integrated agro-based company with a strong...
Synopsis: Sun Pharma is reportedly exploring a ~$10 billion acquisition of US-based Organon to expand its US presence, leveraging Organon’s $1.6 billion quarterly revenue, $660 million biosimilars business, and women’s health portfolio. This company is engaged in the...
